sefulness of FAMT-PET to predict the response after chemotherapy in patients withmalignant lymphoma
Not Applicable
- Conditions
- malignant lymphoma
- Registration Number
- JPRN-UMIN000025980
- Lead Sponsor
- Gunma Univetsity
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1) Pregnant woman 2) Patients with obvious interstitial pneumonia or pulmonary fibrosis in the chest X-ray. 3) Patients with collagen vascular disease or autoimmune diseases 4) Other cases attending physician it is determined unsuitable for registration of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changeing of SUVmax, MTV and TLG, and the efficacy of chemotherapy Evaluation after 2 cycles from initial chemotherapy
- Secondary Outcome Measures
Name Time Method Survival and adverse events